Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 6/14/2017
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / 0||UN / UN|
Administered by: Other Purchased by: Unknown
Symptoms: General physical health deterioration, Adverse reaction
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? No
Diagnostic Lab Data:
CDC 'Split Type': NO0095075131702NOR006007
Write-up:This spontaneous report as received from a patient''s mother via an another company refers to a female patient of unknown age. There was no information about the patient''s concurrent conditions, concomitant therapies or medical history provided. On an unknown date, the patient was vaccinated with the first dose of GARDASIL (dose, lot # and expiration date were not reported) for prophylaxis. In approximately 2014 (reported as approximately three years ago), the patient experienced a strong reaction with gradual deterioration after vaccination. It was reported that the girl was linked to bed at the time of the report. The outcome of the event was reported as not recovered. The relatedness between the event and GARDASIL was not reported. Upon internal review, the event of strong reaction with gradual deterioration was considered to be serious due to disability. Additional information has been requested.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166